Durect
Price & Volume
Stats
See more52W Range | $0.48-$2.64 |
Market Cap | $59.3M |
Shares Short | 344,959 |
Financials
See moreRevenue (12 Mos) | $1.6M |
Revenue Growth (YoY) | -30.8% |
Gross Profit (12 Mos) | $4.1M |
Diluted EPS | -$0.43 |
News
See moreYahoo Finance • 7 days ago
Bausch Health Companies Inc. (BHC) Acquires DURECT in $413 Million Deal to Tackle Alcoholic Hepatitis
Yahoo Finance • 12 days ago
Bausch Health Completes $63 Mln Acquisition Of DURECT, Adds Breakthrough AH Therapy
Yahoo Finance • 25 days ago
Bausch Health Companies Inc. (BHC) Expands Hepatology Portfolio with DURECT Acquisition
Yahoo Finance • 28 days ago
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
About
CEO | Dr. James E. Brown D.V.M. |
CFO | Mr. Timothy M. Papp M.B.A. |
Address | 10240 Bubb Road, Cupertino, CA, United States, 95014-4166 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 13 |
